For: | Suryadevara V, Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Incretin based therapy and pancreatic cancer: Realising the reality. World J Gastroenterol 2022; 28(25): 2881-2889 [PMID: 35978867 DOI: 10.3748/wjg.v28.i25.2881] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v28/i25/2881.htm |
Number | Citing Articles |
1 |
Carla Micaela Cuttica, Irene Maria Briata, Andrea DeCensi. Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment. Nutrients 2023; 15(17): 3737 doi: 10.3390/nu15173737
|
2 |
Jiaqi Wu, Liang Tang, Feng Zheng, Xun Chen, Lei Li. A review of the last decade: pancreatic cancer and type 2 diabetes. Archives of Physiology and Biochemistry 2023; : 1 doi: 10.1080/13813455.2023.2252204
|
3 |
Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglilar. The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024; 16(9): 1625 doi: 10.3390/cancers16091625
|